Phase I trial of GTP-004 in healthy volunteers

Trial Profile

Phase I trial of GTP-004 in healthy volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 09 Jan 2018

At a glance

  • Drugs GTP-004 (Primary) ; Pyridostigmine
  • Indications Myasthenia gravis
  • Focus Adverse reactions; Proof of concept
  • Most Recent Events

    • 09 Jan 2018 Status changed from recruiting to active, no longer recruiting, according to a GT Biopharma media release.
    • 09 Jan 2018 According to a GT Biopharma media release, dosing of patients has been completed.
    • 13 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top